THE QUARTERLY JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

Gli articoli più letti nelle ultime tre settimane

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):239-53
Conventional and advanced magnetic resonance imaging in patients with high-grade glioma
Whitney B. POPE *, Garth BRANDAL

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):267-70
Advanced differentiated thyroid cancer: when to stop radioiodine?
Luca GIOVANELLA *, Douglas van NOSTRAND

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):355-70
CT radiomics and PET radiomics: ready for clinical implementation?
Marta BOGOWICZ *, Diem VUONG, Martin W. HUELLNER, Matea PAVIC, Nicolaus ANDRATSCHKE, Hubert S. GABRYS, Matthias GUCKENBERGER, Stephanie TANADINI-LANG

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):150-8
Response assessment of bone metastatic disease: seeing the forest for the trees
 RECIST, PERCIST, iRECIST, and PCWG-2
Angelo CASTELLO, Egesta LOPCI *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 June;64(2):143-51
Prognostic and predictive role of the tumor immune landscape
John B. HAANEN *, Christian U. BLANK

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 September;63(3):229-34
Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approach
Luca GIOVANELLA *, Lorenzo SCAPPATICCIO

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 June;63(2):136-49
Molecular imaging of bone metastases using tumor-targeted tracers
Najme KARAMZADE-ZIARATI, Reyhaneh MANAFI-FARID, Bahar ATAEINIA, Werner LANGSTEGER, Christian PIRICH, Felix M. MOTTAGHY, Mohsen BEHESHTI *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2019 December;63(4):323-38
Machine learning for radiomics-based multimodality and multiparametric modeling
Lise WEI, Sarah OSMAN, Mathieu HATT, Issam EL NAQA *

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2018 September;62(3):325-35
Reversible myocardial perfusion defects in patients not suffering from obstructive epicardial coronary artery disease as assessed by coronary angiography
Christophe van de WIELE *, Adriana RIMBU, Tarik BELHOCINE, Bart de SPIEGELEER, Mike SATHEKGE, Alex MAES

The Quarterly Journal of Nuclear Medicine and Molecular Imaging 2020 September;64(3):250-64
Managing radioiodine refractory thyroid cancer: the role of dosimetry and redifferentiation on subsequent I-131 therapy
Maaike DOTINGA *, Dennis VRIENS, Floris van VELDEN, Linda HEIJMEN, James NAGARAJAH, Rodney HICKS, Ellen KAPITEIJN, Lioe-Fee de GEUS-OEI